相关实验视频
Updated: Jun 17, 2025

06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
138
低CYP3A4和中等代谢器具有较高的类固醇诱导眼内压力反应率
Jessica A Wright1, Sarah C Xu2,3, Mitchell H Wong1
1Departments of Pharmacy.
Journal of glaucoma
|August 12, 2024
概括
降低CYP3A4酶活性可能表明类固醇诱导的眼内压力 (IOP) 升高的风险更高. 这一发现可能有助于识别有风险的患者,以便在类固醇治疗期间进行更密切的监测.
科学领域:
- 药物基因组学 药物基因组学
- 眼科医生 眼科 眼科
- 药物新陈代谢 药物新陈代谢
背景情况:
- 类固醇治疗被广泛使用,但可能导致眼内压升高 (IOP).
- 酶细胞P450 3A4 (CYP3A4) 代谢外部类固醇.
- 在CYP3A4的遗传变异可以影响酶活性和药物反应.
研究的目的:
- 调查CYP3A4代谢表型与类固醇诱导的IOP升高风险之间的关联.
- 为了确定CYP3A4基因型是否可以预测因使用类固醇而导致眼睛高血压的易感性.
主要方法:
- 对CYP3A4基因的DNA测序在10,073名患者身上进行.
- 患者根据CYP3A4代谢器表型 (中级/缓慢与正常) 分类.
- 分析了类固醇暴露和IOP变化,不包括先前存在的青光眼患者.
主要成果:
- 降低CYP3A4表型 (低/中等代谢) 的患者在暴露于类固醇后更有可能经历显著的IOP增加 (≥3 mmHg) (59%对23%).
- IOP升高的幅度在各组之间是相似的,但响应的发生率在降低的CYP3A4表型组 (P=0.031) 中显著更高.
- 两组之间没有观察到青光眼家族病史的显著差异.
结论:
- 降低CYP3A4代谢活性与类固醇诱导的IOP升高的风险增加有关.
- CYP3A4表型可以作为预测生物标志物,用于识别因类固醇而易患眼睛高血压的个体.
- 这一发现支持眼科中类固醇治疗的个性化风险评估.
相关概念视频
Open Angle Glaucoma: Treatment
413
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
413
Glaucoma: Overview
530
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
530
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
108
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
108
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Angle Closure Glaucoma: Treatment
459
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
459
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
52
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
52

